u/Analyst-man

ABT trades at 18x forward P/E, is growing mid-single digits, pays a >2.5% dividend, and recently made a $21B acquisition in colorectal testing. The author sees this combination of valuation, growth, yield, and strategic expansion as creating a value investment opportunity. The post implies a long-term buy-and-hold investment in a diversified healthcare leader. Acquisition integration risk, slower-than-expected growth, multiple compression if earnings disappoint, or broader healthcare sector headwinds.